SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
BLUD Analysis & Videos »
BLUD: Bull or Bear?
Immucor (BLUD): Two experts bank on blood bank buy
BLUD
-27.53%
in
262 days
Filed under: Newsletters, Stocks to Buy, Recession, Obama Picks Two leading growth stock expert, Brandon Clay, editor of Invest with an Edge, and Alexander Green, editor of The Oxford Club, turn to automated blood testing equipment maker Immucor (NASDAQ: BLUD) as a recession-resistant buy. <>Clay suggest, "A good bet is to go with the strongest stock in that particular sector at the time of your pickThat way, the company you select at least has the momentum of the sector backing it. Typically the medical industry performs better than the overall market in a downturn. This recession has been no...
|
Immucor Inc
BLUD
|
|
|
-41.67%
in
463 days
Immucor is out for blood that is testing blood for antibodies and other serum components prior to transfusions. With its acquisition of Gamma Biologicals and Biopool International in the past decade, this market leader in blood testing systems sales has had a 2,893% rate of return. Rising stock prices from $1.14 in 97 to $33.39 in 07 has been a result of its worldwide expansion. Their recent double-digit sales growth is generating investor interest today. A covered call investing position for BLUD is currently available for August stock options expiration with a potential return ...
|
Good Flow for BLUD Shares
BLUD
-28.01%
in
498 days
Gross margins are expected to regain momentum from the eventual growth in reagent sales, manufacturing efficiencies, and price increases. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experime...
|
Immucor (BLUD): Shares define bullish 'flag' pattern
BLUD
-30.12%
in
586 days
Filed under: Earnings reports, Technical Analysis, Stocks to Buy Immucor (NASDAQ: BLUD) provides automated systems used by hospitals, clinical laboratories and blood banks to detect and identify certain properties of the cell and serum components of human blood prior to transfusion. Products are primarily used to type blood and detect foreign antibodies. Immucor sells its systems and reagent tests directly in North America, Western Europe and Japan. <>The company made news earlier in the week, when it reported Q3 EPS of 27 cents and revenues of $67.3 million. Analysts had been looking for 22 ce...
|
Immucor (BLUD)
BLUD
|
|
|
-28.90%
in
587 days
Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice ! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any investment decisions based on information on this website. <>  With the market acting a little more reasonable today, I wanted to find a stock that fit my criteria that I could share with all of you. Going to my usual 'first step' in identifying stocks, I noted that Immucor (BLUD) had made the list of top % gainers on the Nasdaq to...
|
Immucor (BLUD)
BLUD
|
|
|
-28.70%
in
164 days
(closed on 04/03/08)
Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice ! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any investment decisions based on information on this website. A few moments ago my Immucor (BLUD) stock hit a sale point at an (8)% loss. I sold 154 shares at $34.90. These shares were purchased only a couple of weeks ago, on October 4, 2007, at a cost basis of $38.02. Thus, I had a loss of $(3.12)/share or (8.2)% since purchase. <> Sinc...
|
Immucor (BLUD)
BLUD
|
|
|
+6.75%
in
199 days
(closed on 10/22/07)
As I reported earlier today, after reviewing my AZZ stock purchase closely (after I hastily purchased some shares) I realized that fiscal year 2008 had been guided lower. The stock is still an interesting selection, but it doesn't really fit my own strategy of looking for stocks with growing revenue and increasing earnings. Especially when the company announces that the upcoming year will be a downturn for its results. I can go down a list of excuses why I missed that story before I purchased the stock, but excuses are excuses and I simply made a mistake. <>Looking through the <>list ...
|
People Bullish on BLUD
People Bearish on BLUD
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on BLUD |
Be the first to start a discussion and earn 2 points.
More Resources
|
About Immucor Inc
- Answers.com
